Network Meta-Analysis of Efficacy and Safety of Chemotherapy and Target Therapy in the First-Line Setting of Advanced Pancreatic Cancer

Both gemcitabine and fluoropyrimidine are recommended backbones in the first-line treatment of pancreatic ductal adenocarcinoma (PDAC). To compare the efficacy and safety of these two therapeutic backbones, and to investigate the optimal therapies, we conducted a network meta-analysis. By retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Kun-I, Yang, Jia-Lian, Lin, Yu-Chao, Chou, Che-Yi, Chen, Jin-Hua, Hung, Chin-Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895788/
https://www.ncbi.nlm.nih.gov/pubmed/31703359
http://dx.doi.org/10.3390/cancers11111746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895788/
https://www.ncbi.nlm.nih.gov/pubmed/31703359
http://dx.doi.org/10.3390/cancers11111746

Ejemplares similares